The fields of gene editing and gene therapy have been growing since the first draft of the human genome map was finished in 2003. In 2022, gaps in that map were completed. But even before then, the roadmap gave researchers the opportunity to develop gene therapies to correct genetic abnormalities. Gene editing, which seeks to directly alter a patient’s genome itself,…
The stock market is recovering with solid earnings reports and the decision of the Fed to maintain the interest rate at the same level. While it will have a short-term positive impact on the market, investors who are looking to buy and hold for the long term need to look beyond the current ups and downs. Amid this development, it…
It’s the dream of every investor to uncover stocks with the potential to grow tenfold within a short span. While it may sound like a lofty goal, the article reveals that it’s not just a pipe dream. The article delves into the exciting journeys of three companies making waves in their respective industries. These are the stocks that can 10X…
The selloff in stocks continues. The downturn that began in August and accelerated in September is ongoing as we near the end of October. Since Aug. 1, the benchmark S&P 500 index has declined 7%. The drop in equities has largely been broad-based with few names or sectors spared. That said, there are a few stocks bucking the current downtrend and rising. A handful…
As the third-quarter earnings season gets underway, the market remains volatile and unpredictable. With war breaking out in the Middle East and bond yields remaining elevated, equities have been gyrating lately. However, within this environment, there are several stocks that are trading at 52-week highs and fast approaching all-time highs. While some of these names are obvious, others might surprise you.…
Biotech stocks have had a rough post-pandemic. In a year where the S&P500 is up more than 10% year to date, the biotech sector is still negative to flat. But biotech stocks will bounce back. Some biotech stocks will remain very volatile, especially small biotechs relying on clinical trials. However, the broader sector is still poised for consistent growth. As our population ages…
AI is the market’s darling of the year, and some experts and participants are focusing on “Big Tech,” like Amazon (NASDAQ:AMZN) and Apple (NASDAQ:AAPL). Meanwhile, a few stocks are silently gaining momentum and producing exceptional returns. Their movements haven’t been noticed due to the nature of their price performance — which is to say they don’t give out a 20% return in a day.…
Most of the time, preferred stock shares are pretty boring. However, the rapid increase in interest rates has turned a subset of the preferred universe into potentially outstanding investment opportunities. You could dig out the right preferred stocks yourself or invest in an ETF that does precisely that. Let me show you how to do both for some above-average income……
Discerning investors are locking their radars onto the top renewable energy stocks in navigating the rapidly transforming energy landscape. These stocks aren’t just bright spots on the horizon; they represent critical pillars underpinning the global shift towards clean, sustainable power. The International Energy Agency forecasts a surge in electricity demand, set to rev up this year, propelled by the proliferation of electric…
When it comes to investing in top penny stocks, a word of caution. Do your due diligence before buying. Make sure it has volume. And know upfront that you can lose a lot of money. Sure, some penny stocks turned out to be massive success stories, like Apple, Ford Motor, and Monster Beverage. However, you have to be willing to do…